The Lettsomian Lectures on Diseases and Disorders of the Heart and Arteries
Advertisement
The Lettsomian Lectures on Diseases and Disorders of the Heart and Arteries
The Lettsomian Lectures on Diseases and Disorders of the Heart and Arteries
This book covers the following topics: Natural State of Heart and Arteries
after 40, Causes of cardio-vascular disorder and disease, Physical Stress ,
Nervous Influences, Cardiac Poisons, Disturbances of Metabolism, Gout, Syphilis,
Acute specific fevers, Chronic affections, Complex causes, Old-standing
Rheumatic Lesions, Family heart.
This note describes the
clinical symptoms and signs of valvular heart disease and the etiology,
pathology, and natural history of valvular heart disease.
One of the most challenging
scientific steps of the modern era has been the ability to replace, functionally
or anatomically, the failing heart, and in December 2017 we celebrated the 50th
anniversary of the worlds first human heart transplant. Despite a long and
troubled hystory, heart transplantation has dramatically expanded over time, and
is currently the gold standard solution in terms of treatment of refractory
end-stage heart failure. Topics covered includes: Heart Transplant, Donor Heart
Allocation, Heart Transplantation in the Era of the Left Ventricular Assist
Devices, Surgical Management for Advanced Heart Failure in Adults with
Congenital Heart Disease, Orthotopic Heart Transplantation, Heterotopic Heart
Transplantation, Anesthesia and Intensive Care Management for Cardiac
Transplantation, Graft Vascular Disease, Post-Heart Transplantation
Lymphoproliferations, Cardiac Re-Transplantation.
The major
objective of this lecture note is for the students to gain an
understanding of the structure and function of the cardiovascular and
respiratory systems through lectures, laboratory exercises, patient
presentation and small group conferences.
The need
for this guideline was identified as the NICE guidelines on chronic
heart failure were being updated. We recognized at this time that there
were important aspects of the diagnosis and management of acute heart
failure that were not being addressed by the chronic heart failure
guideline, which focussed on long term management rather than the
immediate care of someone who is acutely unwell as a result of heart
failure. The aim of this guideline is to provide guidance to the NHS on
the diagnosis and management of acute heart failure. Topics covered
includes: Diagnosis, assessment and monitoring, Initial pharmacological
treatment, Initial non-pharmacological treatment, Treatment after
stabilisation, Valvular surgery and percutaneous intervention,
Mechanical assist devices.
Author(s): National Clinical Guideline Centre 2014
The opening chapters are devoted to a
description of instrumental and graphic methods in the study and examination of
normal and abnormal rhythms and of normal and abnormal silhouettes. Subsequent
chapters are devoted to the purely clinical side of cardiology. Careful
consideration is given to the important subjects of the pathology, etiology,
diagnosis, prognosis, and therapy of endocarditis, myocarditis, and
cardiosclerosis.
This note covers the following topics: Signs and symptoms,
Diagnosis, Overview of Atherosclerosis, Etiology of Atherosclerosis,
Risk Factors for Atherosclerosis, Epidemiology of Atherosclerosis,
Patient Education in Atherosclerosis, Patient History, Physical
Examination, Lipid Profile, Blood Glucose and Hemoglobin A1C,
Ultrasonographic Examination, MRI and Scintigraphy, Treatment of
Atherosclerosis and Drug Agents.
This note covers the following topics:Uncontrolled Blood
Pressure, History and physical examination, Evaluation of uncontrolled
hypertension, Malignant hypertension
This note covers the following topics: Prognosis, Vascular Signs
and Sites of Occurrence, Differential Diagnosis, Laboratory, Imaging,
and Histologic Studies, Fluorescein Angiography, Laser Treatment,
Surgical Evacuation.
This note covers the following topics related to
Nephrosclerosis treatment and medication: Medical Care, Diuretics, ACE
inhibitors, Renin inhibitors, Calcium channel blockers, Direct
vasodilators, Central-acting alpha-2 agonists, Alpha-1 antagonists,
Antihypertensives, Low-dose thiazides, ACE inhibitor and ARB
combination therapy.
This note covers the following topics:Risk Assessment and
Primary Prevention, Classification of Recommendations, Secondary
Prevention Goals and Management, Women and Coronary Artery Disease.